Salem Investment Counselors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3K Hold
49
﹤0.01% 1056
2026
Q1
$3.08K Buy
+49
New +$3.41K ﹤0.01% 1030
2025
Q4
Sell
-49
Closed -$3.3K 599
2025
Q3
$3.3K Hold
49
﹤0.01% 1034
2025
Q2
$4.28K Hold
49
﹤0.01% 963
2025
Q1
$3.35K Hold
49
﹤0.01% 980
2024
Q4
$3.81K Hold
49
﹤0.01% 956
2024
Q3
$3.29K Hold
49
﹤0.01% 970
2024
Q2
$5.56K Hold
49
﹤0.01% 907
2024
Q1
$6.8K Buy
+49
New +$6.16K ﹤0.01% 888
2021
Q1
Sell
-12
Closed -$1K 867
2020
Q4
$1K Buy
+12
New +$1.07K ﹤0.01% 771
2020
Q3
Sell
-88
Closed -$9K 704
2020
Q2
$9K Hold
88
﹤0.01% 558
2020
Q1
$6K Hold
88
﹤0.01% 557
2019
Q4
$5K Buy
+88
New +$4.17K ﹤0.01% 605
2017
Q3
Sell
-912
Closed -$17K 595
2017
Q2
$17K Buy
+912
New +$16.8K ﹤0.01% 417

Other funds holding DXCM

Salem Investment Counselors's DXCM Position: Q2 2026 in Review

Salem Investment Counselors held its DexCom (DXCM) position steady in Q2 2026 at 49 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Salem Investment Counselors first reported a position in DXCM in Q2 2017 and has held it in 14 quarters since. The position peaked at $17K in Q2 2017. 320 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Salem Investment Counselors held 49 shares of DexCom worth $3.3K as of Q2 2026.
  • Salem Investment Counselors left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1056 holding.
  • Salem Investment Counselors first reported a position in DexCom in Q2 2017 and has held it in 14 quarters since.
  • Salem Investment Counselors's DexCom position peaked at $17K in Q2 2017.
  • 320 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.